Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heart Rate Variability Response to Metformin Challenge
NCT02500628Phase 2Completed
- Sponsor
- Woodinville Psychiatric Associates
- Start
- Jul 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in fibromyalgia (FM), mitochondrial disease, movement disorder, type 2 diabetes mellitus (T2DM), sponsored by Woodinville Psychiatric Associates. Started Jul 2015; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
fibromyalgia (FM)mitochondrial diseasemovement disordertype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02500628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02500628.